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INTRODUCTION
Central venous stenosis (CVS) is a common problem in 
patients with a long standing implanted central venous 
catheter or a compressing mediastinal mass and this can 
lead to a critical situation with facial and neck swelling, 
distended neck veins, headache due to cerebral edema, 
dyspnea and in severe cases stridor and mental changes (1). 
In this situation stenting of the affected venous vessels 
(superior vena cava [SVC], left brachiocephalic vein [LBV], 
right brachiocephalic vein [RBV] left/right internal jugular 
vein [LJV/RJV] and left/right subclavian vein [LSV/RSV]) 
via the endovascular approach is an effective treatment 
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option (2). However, in-situ catheter-material such as port- 
or hemodialysis catheters pose the problem of catheter-
fixation to the vessel wall and this is possibly followed 
by functional deficiency due to catheter compression 
or catheter defects caused by the expanded stent (3). 
Therefore, the catheter material may temporarily be removed 
before stent implantation. So far this procedure has only 
been described for the SVC (3-6).
In this case report we describe a complex procedure with 
an in situ port catheter which was temporarily repositioned 
for stent implantation in the SVC and LBV. 
CASE REPORT
A 54 year-old male patient with a central bronchial 
carcinoma (UICC stage IIIb) was referred to our clinic with 
symptoms of CVS, including distended neck veins, plethora 
of the face and upper extremities and dyspnea, for palliative 
SVC stenting. He had undergone left-sided subclavian port 
implantation nine months before for chemotherapy with 
Cisplatin and Vinorelbin in combination with external beam 
radiotherapy. Since there was no sufficient response to the 
first-line therapy, the medication was replaced by second-
line therapy with Gemzar and Navelbine. Because of tumor Korean J Radiol 12(5), Sep/Oct 2011 kjronline.org 630
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progression, his CVS symptoms were considered to be due 
to tumor-related SVC stenosis and the patient was referred 
to our hospital for SVC stenting. The RJV was punctured 
with an 18G needle and biplane diagnostic angiography 
revealed a compression of the SVC at the level of the tumor 
which was causing a high grade SVC stenosis (Fig. 1A, G). 
Thereafter, a 7 Fr-introducer sheath (Pinnacle Introducer 
sheath, Terumo, Tokyo, Japan) was inserted and additional 
diagnostic angiography of the LBV was performed: this 
showed a subtotal stenosis of the LBV in its central two-
thirds (Fig. 1B, G). After repositioning the tip of the 
port-catheter into the RBV using a 15 mm Andra-snare 
(Angiopro, Speyer, Germany), a self-expandable stent (14 
mm diameter; 40 mm length Sinus-Repo-stent, Optimed, 
Ettlingen, Germany) was placed in the SVC without prior 
balloon dilatation (Fig. 1C, H). Balloon dilation was 
performed after placement of the self expandable stent 
in the SVC using a 10 mm diameter, 40 mm length Fox 
balloon (Abbott Laboratories, Abbott Park, IL) (Fig. 1C, D). 
Thereafter, the LJV was punctured and a 7 Fr-introducer 
sheath (Terumo, Tokyo, Japan) was introduced (Fig. 1D). 
Using the same 15 mm Andra-snare, the port-catheter was 
repositioned in the distal part of the LBV and it was fixed 
there by keeping the loop-wire of the snare around the port 
catheter, while the catheter of the snare was removed (Fig. 
1E, I). Then the LBV stenosis was crossed with a guide-
wire via the same sheath while the loop wire remained in 
place and two stents (12 mm diameter/40 mm length, and 
12 mm diameter/60 mm length, respectively, Sinusflex-
Repo, Optimed, Ettlingen, Germany) were placed via the 
same introducer sheath in the LBV, extending from the SVC 
to the LBV after pre-ballooning the stenosis with a 8 mm 
diameter/40 mm length Fox balloon (Abbott Laboratories) 
(Fig. 1I). Finally, the snare`s catheter was inserted again 
and the port catheter was repositioned through the newly 
implanted catheter into the SVC (Fig. 1F, J). After manual 
compression the introducer sheaths were removed. The signs 
of CVS regressed within a few hours and the patient was 
discharged the same day with markedly short- and midterm 
symptom relief. The patient died two months later due to 
tumor progression without any signs of CVS. 
DISCUSSION
Central venous stenosis is a common problem in patients 
with mediastinal tumors and/or central venous catheters 
with an incidence of 11% to 50% depending on the 
catheter type and access route (6-8). Interestingly, catheter 
associated stenosis occurs more often in patients with a 
subclavian central venous access (42%) than in patients 
with an internal jugular venous access (10%). CVS is more 
often seen with left sided central venous catheters than 
with right sided central venous catheters, and this is 
possibly due to a longer and more tortuous course of the 
left-sided catheters through the LBV (9). The treatment of 
CVS using percutaneous transluminal angioplasty (PTA) and 
stenting is a well accepted technique with usually rapid 
symptom relief in these patients (2, 5, 8). The complications 
of this procedure, including rupture of the SVC or stent 
migration, are rare (2). An in situ central venous catheter is 
usually removed before stenting to prevent catheter fixation 
between the stent and the vessel wall with the associated 
risk of catheter dysfunction or catheter loss (3). To avoid 
catheter removal and the associated strain and risks of a 
new central venous puncture (e.g. bleeding, pneumothorax 
and air embolism) for the patient, a technique that allows 
stenting of the SVC without removal of central venous 
catheters has been proposed by several authors (5, 6).
In this case report we describe the combined stenting of 
the SVC and the LBV with an in-situ central-venous catheter 
in a patient with SVC stenosis due to bronchial cancer, 
which was treated with external beam radiation therapy and 
multiple courses of chemotherapy, and a second stenosis 
in the proximal two-thirds of the LBV in the presence of a 
central venous port catheter. Due to the coincidence of the 
stenosis and catheter position in the LBV, we suspected the 
LBV stenosis as being the result of catheter-related scarring 
(Fig. 1B, G). To prevent the removal of the central venous 
catheter, it has to first be dislocated in the RJV before SVC 
stent implantation (Fig. 1H). Thereafter, it was dislocated 
in the distal LBV using a snare (Fig. 1E, I). The removal of 
the snare-catheter while the central venous catheter was 
held in place with the snare-wire allowed the simultaneous 
introduction of the stents through the same 7 Fr sheath 
and this avoided another venous puncture and sheath 
insertion (Fig. 1F, I). Further, another angiographic control 
procedure of the central venous catheter could be avoided 
prior to repositioning because the central venous catheter 
was constantly fixed with the snare and it was ready to be 
advanced in its original position. This approach is on the 
one hand convenient for the experienced interventionalist 
and it is also convenient for the patient since no new 
central venous catheter has to be placed. Further, one 
venous puncture and sheath insertion were avoided by using Korean J Radiol 12(5), Sep/Oct 2011 kjronline.org 631
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Fig. 1. Angiographic and schematic illustration of procedure.
A. Diagnostic angiography showing severe stenosis of superior vena cava (arrow). B. Diagnostic angiography of left brachiocephalic vein reveals 
subtotal stenosis (arrows). C. After repositioning tip of port-catheter into right brachiocephalic vein using 15 mm Andra-snare, self-expandable 
stent is placed in superior vena cava (arrows). D. Left jugular vein is punctured and 7 Fr introducer sheath is introduced (arrowhead). Released 
stent in superior vena cava (arrow).Korean J Radiol 12(5), Sep/Oct 2011 kjronline.org 632
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one sheath for the snare and the stents, and this reduced 
the risk of pneumothorax, bleeding and air embolism. 
Additionally, this procedure is cost-effective compared to 
the standard procedure since no new port system has to be 
implanted.
The first introducer sheath was inserted in the RJV 
because of the known SVC stenosis. Due to the lack of 
proper preinterventional imaging, the LBV stenosis was 
discovered on the first diagnostic angiograms. In retrospect, 
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Fig. 1. Angiographic and schematic illustration of procedure.
E. Using Andra-snare (arrow), port-catheter (arrowhead) is repositioned in distal part of left brachiocephalic vein and is fixed there by keeping 
loop-wire of snare around port catheter, while snare’s catheter is removed. F. Left brachiocephalic vein stenosis is crossed with guide-wire via 
same sheath while snare’s loop wire remains in place and two 12 mm stents (arrow) are placed via same introducer sheath in left brachiocephalic 
vein, extending from superior vena cava to left brachiocephalic vein. Finally snare’s catheter is inserted again and port catheter is repositioned 
into superior vena cava  (arrowhead). G-J. Schematic drawing of procedure. Initial situation with stenosis in superior vena cava and left 
brachiocephalic vein and in situ port catheter (G). Port catheter is repositioned in right brachiocephalic vein using snare before stent is 
placed in superior vena cava (H). Then port catheter is positioned in distal part of left brachiocephalic vein and two stents are placed in left 
brachiocephalic vein and superior vena cava via same sheath (I). Final situation with preserved port catheter (J).
the puncture of the RJV was not necessary since all the 
stent and snare insertions could have been performed via a 
single introducer sheath placed in the LBV, which highlights 
the value of adequate pre-interventional imaging, such 
as contrast-enhanced CT, for treatment planning. In 
contrast to the previous reports by Bovenschulte et al. (3) 
and Palmié et al. (4) we used an internal jugular venous 
access route instead of a femoral venous access route. This 
approach is known to reduce the rate of venous thrombosis Korean J Radiol 12(5), Sep/Oct 2011 kjronline.org 633
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and post-punctional infections (10). It also facilitated 
proximal catheter displacement.
In conclusion, SVC and LBV stenting in a patient with 
CVS while preserving existing ventral venous catheters is 
feasible via a single venous access. The procedure is safe 
and it improves the patient’s quality of life, while omitting 
the need for a second intervention for central venous 
catheter re-insertion. 
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